Author:
Friedberg Joseph S.,Simone Charles B.,Culligan Melissa J.,Putt Mary E.,Barsky Andrew R.,Katz Sharyn,Cengel Keith A.
Funder
National Cancer Institute of the National Institutes of Health
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery
Reference9 articles.
1. French Cooperative Thoracic Intergroup (IFCT). Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial;Zalcman;Lancet,2016
2. Extended pleurectomy/decortication-based treatment for advanced stage, large tumor volume mesothelioma yielding a median survival of 3 years;Friedberg;Ann Thorac Surg,2017
3. Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England;Damhuis;Lung Cancer,2015
4. Number of mediastinal lymph nodes as a prognostic factor in PN2 non small cell lung cancer: a single centre experience and review of the literature;Takanen;Asian Pac J Cancer Prev,2014
5. Friedberg J, Culligan M, Putt M, et al. Posterior intercostal lymph nodes affect prognosis for surgery-based treatment of malignant pleural mesothelioma and should be considered N2 lymph nodes. Paper presented at the 12th International Conference of the International Mesothelioma Interest Group (iMig 2014), October 21-24, 2014, Cape Town, South Africa.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献